Dow Up 0.15% Nasdaq Up 0.10%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.56 Up 0.01(0.39%) 9:31AM EDT - Nasdaq Real Time Price
Prev Close:2.55
Open:N/A
Bid:2.55 x 5000
Ask:2.57 x 13300
1y Target Est:4.90
Beta:1.64
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:2.56 - 2.57
52wk Range:1.07 - 4.25
Volume:11,939
Avg Vol (3m):1,491,590
Market Cap:369.80M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICUp 0.39%369.80M
BMYUp 0.10%84.26B
RHHBY 0.00%248.76B
SNYDown 0.02%143.75B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback